Condition category
Mental and Behavioural Disorders
Date applied
20/12/2005
Date assigned
20/12/2005
Last edited
03/07/2009
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr J.W. Bloemers

ORCID ID

Contact details

GGZ
P.O. Box 286
Winschoten
9670 AG
Netherlands

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

NTR281; ZonMw: 100-103-016

Study information

Scientific title

Acronym

Study hypothesis

Assertive community treatment (ACT) will, compared to care-as-usual, result in less admission days and more sustained contact with mental health. Moreover, life skills will be more improved possibly resulting in a higher quality of life.

Ethics approval

Received from the local medical ethics committee

Study design

Randomised, active controlled, parallel group trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type

Treatment

Patient information sheet

Condition

Psychiatric, mental disorders/illness

Intervention

Assertive community treatment (ACT): in ACT the case load is a shared responsibility for the whole team. ACT is further characterised by:
1. A low staff-to-patient ratio (1 - 10 maximum)
2. In vivo treatment at home of the patient
3. The inclusion of a wide range of disciplines in the ACT team, including client participation

Fidelity is measured by 28 items.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

1. Admissions/admission days
2. Care consumption
3. Sustained contact with mental health
4. Life skills

Secondary outcome measures

1. Psychiatric symptoms
2. Quality of life
3. Satisfaction with care
4. Family burden

Overall trial start date

01/09/2004

Overall trial end date

31/08/2006

Reason abandoned

Eligibility

Participant inclusion criteria

Mental health patients with a Health of the Nation Scales (HoNOS) total score above 14

Participant type

Patient

Age group

Not Specified

Gender

Not Specified

Target number of participants

100

Participant exclusion criteria

Does not comply with the above inclusion criteria

Recruitment start date

01/09/2004

Recruitment end date

31/08/2006

Locations

Countries of recruitment

Netherlands

Trial participating centre

GGZ,
Winschoten
9670 AG
Netherlands

Sponsor information

Organisation

University Medical Centre Groningen (UMCG) (Netherlands)

Sponsor details

Department of General Practice
Hanzeplein 1
Groningen
9713 GZ
Netherlands
+31 (0)50 361 6161

Sponsor type

Hospital/treatment centre

Website

http://www.umcg.nl/azg/nl/

Funders

Funder type

Research organisation

Funder name

The Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

2007 results on http://www.ncbi.nlm.nih.gov/pubmed/17650271

Publication citations

  1. Results

    Sytema S, Wunderink L, Bloemers W, Roorda L, Wiersma D, Assertive community treatment in the Netherlands: a randomized controlled trial., Acta Psychiatr Scand, 2007, 116, 2, 105-112, doi: 10.1111/j.1600-0447.2007.01021.x.

Additional files

Editorial Notes